Before now, biological systems could only be expressed in terms of linear relationships, however, as knowledge grows and new techniques of analysis on biological systems is made available, we are realizing the non-linearity of these systems. The concepts and techniques of nonlinear analysis allow for more realistic and accurate models in science. The Future of Pharmaceuticals: A Nonlinear Analysis provides an opportunity to understand the non-linearity of biological systems and its application in various areas of science, primarily pharmaceutical sciences. This book will benefit professionals…mehr
Before now, biological systems could only be expressed in terms of linear relationships, however, as knowledge grows and new techniques of analysis on biological systems is made available, we are realizing the non-linearity of these systems. The concepts and techniques of nonlinear analysis allow for more realistic and accurate models in science. The Future of Pharmaceuticals: A Nonlinear Analysis provides an opportunity to understand the non-linearity of biological systems and its application in various areas of science, primarily pharmaceutical sciences. This book will benefit professionals in pharmaceutical industries, academia, and policy who are interested in an entirely new approach to how we will treat disease in the future. Key Features: Addresses a new approach of nonlinear analysis. Applies a theory of projection to chalk out the future, instead of basing on linear evolution. Provides an opportunity to better understand the non-linearity in biological systems and its applications in various areas of science, primarily pharmaceutical sciences. Helps change the thought process for those looking for answers to their questions which they do not find in the linear relationship approach. Encourages a broader perspective for the creative process of drug development.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Sarfaraz K. Niazi, Ph.D., is an Adjunct Professor at the University of Illinois and University of Houston; he has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the field of bioprocessing, drug discovery, mRNA vaccines, drug formulations, thermodynamic systems, alcohol aging, nutraceuticals and treatment of autoimmune diseases. He has established multiple biotechnology projects, from concept to market. He also serves as an advisor to major pharmaceutical and biopharmaceutical companies, regulatory agencies, the FDA, the US Congress, and several heads of state. He is also a patent law practitioner.
Inhaltsangabe
Preface.....................................................................................................................................................xix Acknowledgments.................................................................................................................................xxvii Author....................................................................................................................................................xxix Glossary of Important Terminology......................................................................................................xxxi 1 Understanding Nonlinearity............................................................................................................ 1 2 The Evolution of Pharmaceuticals................................................................................................. 23 3 Artificial Intelligence...................................................................................................................... 69 4 Drug Discovery Trends................................................................................................................... 91 5 Drug Development Assays.............................................................................................................143 6 Nanomedicine................................................................................................................................ 195 7 Antimicrobials................................................................................................................................231 8 Therapeutic Proteins......................................................................................................................251 9 Manufacturing Trends................................................................................................................. 307 10 Therapeutic Protein Delivery Systems........................................................................................ 345 11 Gene and Cell Therapy..................................................................................................................381 12 Nucleic Acid Vaccines....................................................................................................................421 13 Botanical Products........................................................................................................................ 439 14 Regulatory Optimization.............................................................................................................. 469 15 Intellectual Property......................................................................................................................531 Index........................................................................................................................................................557
